このエントリーをはてなブックマークに追加
ID 65530
フルテキストURL
著者
Matsuo, Toshihiko Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University ORCID Kaken ID publons researchmap
Hiramatsu‐Asano, Sumie Department of Rheumatology, Kawasaki Medical School
Sawachika, Hiroshi Department of Rheumatology, Kawasaki Medical School
Nishimura, Hirotake Department of Pathology, Kawasaki Medical School
抄録
Key Clinical Message: Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, specifically with myeloperoxidase (MPO)-ANCA, would have a risk for developing corneal melt and perforation abruptly in a short period. It is desirable to have a team of collaboration of rheumatologists and other specialties.
Abstract: An 80-year old man who had been diagnosed 5.5 years previously as ANCA-associated vasculitis by temporal artery biopsy developed corneal melt and perforation with scleritis in both eyes. He underwent successful cataract surgery and retained ambulatory vision with the aid of intravenous rituximab. Two additional patients with similar manifestations were found in the literature.
キーワード
ANCA-associated vasculitis
corneal melt and perforation
rituximab
scleritis
temporal artery biopsy
発行日
2023-06-20
出版物タイトル
Clinical Case Reports
11巻
6号
出版者
Wiley
開始ページ
e7595
ISSN
2050-0904
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2023 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
関連URL
isVersionOf https://doi.org/10.1002/ccr3.7595
ライセンス
http://creativecommons.org/licenses/by-nc/4.0/
Citation
Matsuo T, Hiramatsu-Asano S, Sawachika H, Nishimura H. ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review. Clin Case Rep. 2023;11:e7595. doi:10.1002/ccr3.7595